Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

Related Articles by Review for PubMed (Select 21444333)

1.

What is the cost of pelvic inflammatory disease and how much could be prevented by screening for chlamydia trachomatis? Cost analysis of the Prevention of Pelvic Infection (POPI) trial.

Aghaizu A, Adams EJ, Turner K, Kerry S, Hay P, Simms I, Oakeshott P.

Sex Transm Infect. 2011 Jun;87(4):312-7. doi: 10.1136/sti.2010.048694. Epub 2011 Mar 28.

PMID:
21444333
2.

Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials.

Gottlieb SL, Xu F, Brunham RC.

Sex Transm Dis. 2013 Feb;40(2):97-102. doi: 10.1097/OLQ.0b013e31827bd637. Review.

PMID:
23324973
3.

Preventing infective sequelae of abortion.

Penney GC.

Hum Reprod. 1997 Nov;12(11 Suppl):107-12. Review.

PMID:
9433966
4.

Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.

van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.

Int J Epidemiol. 2004 Apr;33(2):416-25. Review.

5.

Chlamydial pelvic inflammatory disease.

Paavonen J, Lehtinen M.

Hum Reprod Update. 1996 Nov-Dec;2(6):519-29. Review.

6.

Acute pelvic inflammatory disease.

Eschenbach DA.

Urol Clin North Am. 1984 Feb;11(1):65-81. Review.

PMID:
6369707
7.

Chlamydia trachomatis: impact on human reproduction.

Paavonen J, Eggert-Kruse W.

Hum Reprod Update. 1999 Sep-Oct;5(5):433-47. Review.

8.

Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening.

Land JA, Van Bergen JE, Morré SA, Postma MJ.

Hum Reprod Update. 2010 Mar-Apr;16(2):189-204. doi: 10.1093/humupd/dmp035. Epub 2009 Oct 14. Review.

9.
10.

Prevention of pelvic inflammatory disease by the control of C. trachomatis infection.

Honey E, Templeton A.

Int J Gynaecol Obstet. 2002 Sep;78(3):257-61. Review.

PMID:
12384275
11.

Epidemiological, social, diagnostic and economic evaluation of population screening for genital chlamydial infection.

Low N, McCarthy A, Macleod J, Salisbury C, Campbell R, Roberts TE, Horner P, Skidmore S, Sterne JA, Sanford E, Ibrahim F, Holloway A, Patel R, Barton PM, Robinson SM, Mills N, Graham A, Herring A, Caul EO, Davey Smith G, Hobbs FD, Ross JD, Egger M; Chlamydia Screening Studies Project Group.

Health Technol Assess. 2007 Mar;11(8):iii-iv, ix-xii, 1-165. Review.

12.

Screening for chlamydial infection.

Nelson HD, Helfand M.

Am J Prev Med. 2001 Apr;20(3 Suppl):95-107. Review.

PMID:
11306238
13.

Cost effectiveness of screening for Chlamydia trachomatis: a review of published studies.

Honey E, Augood C, Templeton A, Russell I, Paavonen J, Mårdh PA, Stary A, Stray-Pedersen B.

Sex Transm Infect. 2002 Dec;78(6):406-12. Review.

14.

Developments in the screening for Chlamydia trachomatis: a review.

Kohl KS, Markowitz LE, Koumans EH.

Obstet Gynecol Clin North Am. 2003 Dec;30(4):637-58. Review.

PMID:
14719842
15.

Pelvic inflammatory disease. From diagnosis to prevention.

Paavonen J.

Dermatol Clin. 1998 Oct;16(4):747-56, xii. Review.

PMID:
9891675
16.

Risk of sequelae after Chlamydia trachomatis genital infection in women.

Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB.

J Infect Dis. 2010 Jun 15;201 Suppl 2:S134-55. doi: 10.1086/652395. Review.

17.

Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies.

Herzog SA, Heijne JC, Althaus CL, Low N.

Sex Transm Dis. 2012 Aug;39(8):628-37. doi: 10.1097/OLQ.0b013e31825159ff. Review.

PMID:
22801346
18.

Chlamydia trachomatis screening in family planning centers: a review of cost/benefit evaluations in different countries.

Henry-Suchet J, Sluzhinska A, Serfaty D.

Eur J Contracept Reprod Health Care. 1996 Dec;1(4):301-9. Review.

PMID:
9678112
19.

Effectiveness of chlamydia screening: systematic review.

Low N, Bender N, Nartey L, Shang A, Stephenson JM.

Int J Epidemiol. 2009 Apr;38(2):435-48. doi: 10.1093/ije/dyn222. Epub 2008 Dec 5. Review.

20.

[The risk of pelvic inflammatory disease associated with urogenital infection with Chlamydia trachomatis; literature review].

Boeke AJ, van Bergen JE, Morré SA, van Everdingen JJ.

Ned Tijdschr Geneeskd. 2005 Apr 16;149(16):878-84. Review. Dutch.

PMID:
15868993
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk